$378.55 0.3%
Price vs. AI Score (Last 150 days)
Data gathered: April 17

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

Data Bits

Data Bits Value / Change Benchmark
Job Posts 387 -0.8%
Sentiment 89 2.3%
Webpage traffic 8,000 3.3%
Employee Rating 85 0%
Google Trends 14 0%
Patents 1,812 0%
4chan Mentions 0%
Facebook Engagement 20 -9.1%
Facebook followers 5,081 0.1%
Reddit Mentions 1 0%
Stocktwits Mentions 2 0%
Stocktwits Subscribers 16,654 0%
Twitter Followers 15,120 0.1%
Twitter Mentions 51 -28.2%
News Mentions -100%
Customer reviews 0%
ESG 59 -1.7%
Lobbying Cost $ N/A N/A
Business outlook 87 0%
Linkedin Employees 9,835 N/A

About Intuitive Surgical

Intuitive Surgical Inc designs, manufactures, markets da Vinci Surgical Systems, and related instruments. The da Vinci surgery, combines the benefits of minimally invasive surgery for patients with the ease of use, precision and dexterity of open surgery.

Intuitive Surgical
Price $378.55
Target Price Sign up
Volume 1,580,000
Market Cap $134B
Dividend Yield 0%
PE Ratio 75.17
Revenue per Employee $628,391
Earnings Date April 18 '24
Industry Medical Devices

In the news

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q4 '232.08B1.22B1.28B606M455M1.600
Q3 '231.86B1.03B1.17B416M471M1.460
Q2 '231.86B1.05B1.17B421M468M1.420
Q1 '231.81B1.07B1.11B355M393M1.230
Q4 '221.77B1.05B1.11B325M380M1.230

Insider Transactions View All

Widman Fredrik filed to sell 110 shares at $397.1.
March 18 '24
Widman Fredrik filed to sell 110 shares at $397.1.
March 18 '24
DeSantis Robert filed to sell 5,507 shares at $390.2.
March 11 '24
Brosius Mark filed to sell 1,058 shares at $390.2.
March 11 '24
DeSantis Robert filed to sell 5,507 shares at $390.2.
March 11 '24

Congress Trading View All

Politician Filing Date Type Size
Joshua Gottheimer
Feb 15, 24 Buy $1K - $15K
Rohit Khanna
Feb 5, 24 Buy $1K - $15K
Rohit Khanna
Feb 5, 24 Buy $15K - $50K

What is the Market Cap of Intuitive Surgical?

The Market Cap of Intuitive Surgical is $134B.

What is Intuitive Surgical's PE Ratio?

As of today, Intuitive Surgical's PE (Price to Earnings) ratio is 75.17.

How Many People Work at Intuitive Surgical?

As of our latest update, Intuitive Surgical employed approximately 12,120 people worldwide. However, it's important to note that Intuitive Surgical's workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Intuitive Surgical's revenue per employee?

$628,391. To calculate Intuitive Surgical's revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

When does Intuitive Surgical report earnings?

Intuitive Surgical will report its next earnings on April 18 '24.

What is the current price of Intuitive Surgical?

Currently, the price of one share of Intuitive Surgical is $378.55.

How can I analyze the ISRG stock price chart for investment decisions?

The ISRG stock price chart above provides a comprehensive visual representation of Intuitive Surgical's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Intuitive Surgical shares. Our platform offers an up-to-date ISRG stock price chart, along with technical data analysis and alternative data insights.

Does ISRG offer dividends to its shareholders?

As of our latest update, Intuitive Surgical (ISRG) does not offer dividends to its shareholders. Investors interested in Intuitive Surgical should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Intuitive Surgical?

Some of the similar stocks of Intuitive Surgical are Boston Scientific, Edwards Lifesciences, Medtronic, Stryker, and Becton Dickinson and Co.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.